<DOC>
	<DOCNO>NCT02144246</DOCNO>
	<brief_summary>Primary Objective Our primary objective study evaluate satisfaction hormonal contraception sample woman evaluate impact hormonal contraceptive cystic fibrosis ( CF ) disease woman regular menstrual cycle accompany cyclic exacerbation . We hypothesize : 1a ) woman CF perceive overall benefit hormonal contraception satisfy woman CF perceive benefit , 1b ) woman CF cyclic exacerbation decrease Pseudomonas aeruginosa mucoidy conversion use hormonal contraception , 1c ) woman CF cyclic exacerbation improve patient-reported quality life index hormonal contraception , 1d ) woman CF cyclic exacerbation improvement pulmonary function test hormonal contraception . Secondary Objective We plan secondarily evaluate cervical mucus woman CF time ovulation compare healthy control . We hypothesize woman CF ovulatory cervical mucus similar healthy peer .</brief_summary>
	<brief_title>Contraceptive Hormones Women With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Norgestimate</mesh_term>
	<mesh_term>Norgestrel</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>female , reproductive age ( 1840 ) , cyclic CF exacerbation , regular menstrual cycle pregnant , desire pregnancy , contraindication hormonal contraception , currently use hormonal contraception</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>